BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 19345377)

  • 1. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
    Kojima Y; Honda K; Hamada H; Kobayashi N
    J Surg Res; 2009 Nov; 157(1):e63-70. PubMed ID: 19345377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
    J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y; Gilbert JD; Kim JH; Freytag SO
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
    Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.
    Ji X; Zhang J; Cheng L; Wei F; Li H; Liu X; Chen X; Li C; Wang Y; Huang Q
    Exp Eye Res; 2009 Aug; 89(2):193-9. PubMed ID: 19328781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
    Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local tumour irradiation enhances the anti-tumour effect of a double-suicide gene therapy system in a murine glioma model.
    Desaknai S; Lumniczky K; Esik O; Hamada H; Safrany G
    J Gene Med; 2003 May; 5(5):377-85. PubMed ID: 12731086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination gene therapy of lung cancer with conditionally replicating adenovirus and adenovirus-herpes simplex virus thymidine kinase.
    Oh JY; Park MY; Kim DR; Lee JH; Shim SH; Chung JH; Yoon HI; Lee JH; Sung MW; Kim YS; Lee CT
    Int J Mol Med; 2010 Mar; 25(3):369-76. PubMed ID: 20127041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma].
    Tan WL; Xie Y; Wu YD; Zhu WH; Zheng SB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):594-7. PubMed ID: 16762858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
    Wildner O; Morris JC
    J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
    Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S
    Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
    Morris JC; Wildner O
    Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: significance of timing of 5-fluorouracil administration.
    Seo E; Abei M; Wakayama M; Fukuda K; Ugai H; Murata T; Todoroki T; Matsuzaki Y; Tanaka N; Hamada H; Yokoyama KK
    Cancer Res; 2005 Jan; 65(2):546-52. PubMed ID: 15695398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.